Buonaguro L - Search Results

1

Plant-based anti-HIV-1 strategies: vaccine molecules and antiviral approaches.

Scotti N, Buonaguro L, Tornesello ML, Cardi T, Buonaguro FM. Scotti N, et al. Among authors: buonaguro l, buonaguro fm. Expert Rev Vaccines. 2010 Aug;9(8):925-36. doi: 10.1586/erv.10.79. Expert Rev Vaccines. 2010. PMID: 20673014 Review.

2

Induction of neutralizing antibodies and cytotoxic T lymphocytes in Balb/c mice immunized with virus-like particles presenting a gp120 molecule from a HIV-1 isolate of clade A.

Buonaguro L, Racioppi L, Tornesello ML, Arra C, Visciano ML, Biryahwaho B, Sempala SD, Giraldo G, Buonaguro FM. Buonaguro L, et al. Among authors: buonaguro fm. Antiviral Res. 2002 Jun;54(3):189-201. doi: 10.1016/s0166-3542(02)00004-9. Antiviral Res. 2002. PMID: 12062391

3

Induction of systemic and mucosal cross-clade neutralizing antibodies in BALB/c mice immunized with human immunodeficiency virus type 1 clade A virus-like particles administered by different routes of inoculation.

Buonaguro L, Visciano ML, Tornesello ML, Tagliamonte M, Biryahwaho B, Buonaguro FM. Buonaguro L, et al. Among authors: buonaguro fm. J Virol. 2005 Jun;79(11):7059-67. doi: 10.1128/JVI.79.11.7059-7067.2005. J Virol. 2005. PMID: 15890945 Free PMC article.

4

DNA-VLP prime-boost intra-nasal immunization induces cellular and humoral anti-HIV-1 systemic and mucosal immunity with cross-clade neutralizing activity.

Buonaguro L, Devito C, Tornesello ML, Schröder U, Wahren B, Hinkula J, Buonaguro FM. Buonaguro L, et al. Among authors: buonaguro fm. Vaccine. 2007 Aug 10;25(32):5968-77. doi: 10.1016/j.vaccine.2007.05.052. Epub 2007 Jun 11. Vaccine. 2007. PMID: 17629365

5

Report on the AIDS Vaccine 2008 Conference.

Alter G, Ananworanich J, Pantophlet R, Rybicki EP, Buonaguro L. Alter G, et al. Among authors: buonaguro l. Hum Vaccin. 2009 Mar;5(3):119-25. doi: 10.4161/hv.5.3.7557. Epub 2009 Mar 8. Hum Vaccin. 2009. PMID: 19202348

6

High-level expression of the HIV-1 Pr55gag polyprotein in transgenic tobacco chloroplasts.

Scotti N, Alagna F, Ferraiolo E, Formisano G, Sannino L, Buonaguro L, De Stradis A, Vitale A, Monti L, Grillo S, Buonaguro FM, Cardi T. Scotti N, et al. Among authors: buonaguro l, buonaguro fm. Planta. 2009 Apr;229(5):1109-22. doi: 10.1007/s00425-009-0898-2. Epub 2009 Feb 21. Planta. 2009. PMID: 19234717

7

Short communication: limited induction of IL-10 in PBMCs from HIV-infected subjects treated with HIV-VLPs.

Buonaguro L, Tornesello ML, Jewis GK, Buonaguro FM. Buonaguro L, et al. Among authors: buonaguro fm. AIDS Res Hum Retroviruses. 2009 Aug;25(8):819-22. doi: 10.1089/aid.2008.0304. AIDS Res Hum Retroviruses. 2009. PMID: 19630502 Free PMC article.

8

Virus-like particle vaccines and adjuvants: the HPV paradigm.

Buonaguro FM, Tornesello ML, Buonaguro L. Buonaguro FM, et al. Among authors: buonaguro l. Expert Rev Vaccines. 2009 Oct;8(10):1379-98. doi: 10.1586/erv.09.81. Expert Rev Vaccines. 2009. PMID: 19803760 Review.

9

Progress towards development of an HIV vaccine: report of the AIDS Vaccine 2009 Conference.

Ross AL, Bråve A, Scarlatti G, Manrique A, Buonaguro L. Ross AL, et al. Among authors: buonaguro l. Lancet Infect Dis. 2010 May;10(5):305-16. doi: 10.1016/S1473-3099(10)70069-4. Lancet Infect Dis. 2010. PMID: 20417413

10

Generation of HIV-1 Virus-Like Particles expressing different HIV-1 glycoproteins.

Visciano ML, Diomede L, Tagliamonte M, Tornesello ML, Asti V, Bomsel M, Buonaguro FM, Lopalco L, Buonaguro L. Visciano ML, et al. Among authors: buonaguro fm, buonaguro l. Vaccine. 2011 Jul 12;29(31):4903-12. doi: 10.1016/j.vaccine.2011.05.005. Epub 2011 May 17. Vaccine. 2011. PMID: 21596074

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results